VANCOUVER, British Columbia and BOSTON, July 15, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (the “Company”) announced that, under...
VANCOUVER, British Columbia and BOSTON, June 11, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, June 03, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”), an...
VANCOUVER, British Columbia and BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
VANCOUVER, British Columbia and BOSTON, April 02, 2019 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today...
New name reflects evolution of company from development-stage biotech to innovator in predictive medicine TORONTO, Sept. 27 /PRNewswire-FirstCall/ -- IMI International Medical Innovations Inc...
CDN$10 million/US$8.2 million financing positions IMI for future anticipated growth TORONTO, Aug. 30 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations...
Enters into agreement for CDN$10 million/US$8.2 million TORONTO, Aug. 18 /PRNewswire-FirstCall/ -- Predictive medicine company IMI International Medical Innovations Inc. (TSX: IMI; Amex: IME...
- Major ColorectAlert(TM) study with U.S. National Cancer Institute - 25,000-participant PREPARE study underway in life insurance testing market - Expanded scientific validation for PREVU(x...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
銘柄コード | 株価 | 出来高 |
---|---|---|
AAPYKurv Yield Premium Strategy Apple AAPL ETF | US$ 28.6134 (0.00%) | 0 |
AAPXT Rex 2X Long Apple Daily Target ETF | US$ 38.2982 (0.00%) | 0 |
AAPRInnovator Equity Defined Protection ETF 2 Yr to April 2026 | US$ 26.495 (0.00%) | 0 |
AAAUGoldman Sachs Physical Gold ETF Shares | US$ 26.175 (0.00%) | 0 |
AAAAlternative Access First Priority CLO Bond ETF | US$ 25.15 (0.00%) | 0 |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約